THORNTON JOSEPH CLAY
Known title: Interim CFOCIK: 0002128794
Associated companies
Transaction History
| CLOV | ▼ Sell | Open Market | 17,775 | $78K | 8/17/2026 | View on chart |
| CLOV | ▲ Buy | Grant | 54,347 | $0 | 8/12/2026 | View on chart |
| CLOV | ▼ Sell | Open Market | 4,630 | $22K | 7/15/2026 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 16,942 | $59K | 5/16/2026 | View on chart |
| CLOV | ▼ Sell | Tax Withholding | 4,158 | $8K | 4/15/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Clover Health Gains After Earning 5-Star CMS Rating
Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.
Clover Health Gains After Earning 5-Star CMS Rating. Clover Health stock rose after the company secured a 5-star rating for its PPO plan from CMS for 2027. This top score supports the company's long-term outlook and may help attract new members. The news follows a period where the stock was trading near its 52-week high, reflecting positive market sentiment.